Advanced Gastrointestinal Endoscopic Imaging

Stanford University

Status

Terminated

Conditions

Gastrointestinal Diseases

Gastrointestinal Stromal Tumor (GIST)

Gastric (Stomach) Cancer

Treatments

Device: wide field fluorescence system

Device: Dual axis endoscopic microscope

Drug: indocyanine green

Device: CellVizio

Drug: fluorescein

Drug: fluorescent Peptide

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT01034670

U54CA136465 (U.S. NIH Grant/Contract)

IRB-15766 (Other Identifier)

NCI-2021-03446 (Other Identifier)

Details and patient eligibility

About

To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.

Enrollment

3 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:patients be at least 18 years of age,

Either genders

All ethnic backgrounds will be considered.

Patients who are scheduled for endoscopy by one of the investigators will be asked if they are interested in participating in the study.

The study will be open to all patients undergoing endoscopy that do not have exclusion criteria. We will ask all patients if they are participating in any other studies. If they are participating in any other study then we will ask them for more information to determine whether there could be any harm from participating in both studies and if there is then they will not be enrolled. Exclusion Criteria:Patients with unstable vital signs will not be included.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

3 participants in 1 patient group

endoscopy arm

Experimental group

Description:

imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.